−78 ◦C for 15 min then warmed to room temperature and stirred
for 72 h. After this time the solution was filtered, the solid washed
with petrol (20 cm3) and concentrated in vacuo, affording 600 mg
of a pale yellow solid (77%). Crystallisation occurred by cooling
a saturated petrol solution to −35 ◦C. dH (400 MHz, C6D6): 7.73
(2H, d, J = 1.5 Hz, imidazol-2-ylidine), 7.30–7.36 (2H, m, Ar),
7.19–7.23 (5H, m, Ar), 6.62 (2H, d, J = 1.5 Hz, imidazol-2-ylidine),
septet, J = 7.0 Hz, iPr CH), 1.21 and 1.07 (each 12H, d, J = 7.0 Hz,
iPr CH3) ppm. dC (100.63 MHz, CD2Cl2): 165.22 (C, CNHC), 150.76
(C, Ar), 146.53 (CH, Ar), 144.61, 133.94 (C, Ar), 130.36 (CH, Ar),
128.32 (CH, imidazol-2-ylidene), 123.75 (CH, Ar), 116.21 (CH,
imidazol-2-ylidene), 108.32 (CH, Ar), 28.76 (CH, iPr), 24.48, 23.03
(CH3, iPr) ppm. Calc. for C35H41N5BrF6NiP: C 51.56; H 5.07; N
8.59. Found: C 51.43; H 5.16; N 8.65%.
i
2.92 (4H, septet, J = 7.0 Hz, Pr CH), 2.76 (6H, s, py-Me), 1.25
Nickel{2,6-bis-[(3-(2,6-diisopropylphenyl)-imidazol-2-ylidene]-
and 1.15 (each 12H, d, J = 7.0 Hz, iPr CH3) ppm. dC (100.63 MHz,
C6D6): 221.70 (C, CNHC), 148.81 (C, Ar), 146.66 (CH, Ar), 146.43,
138.90, 129.34 (C, Ar), 129.12 (CH, Ar), 128.57, 125.70, 125.03
(C, Ar), 123.79, 121.21, 119.83 (CH, Ar), 28.66, 24.63 (CH3, iPr),
23.88 (CH, iPr), 20.42 (CH3, py-Me) ppm. Calc. for C37H45N5: C
79.39; H 8.10; N 12.51. Found: C 79.50; H 8.13; N 12.44%.
pyridine} acetonitrile bis(tetrafluoroborate), 4·(BF4)−
. Com-
2
pound 3·(Br)− (250 mg, 0.33 mmol) and AgBF4 (136 mg,
0.70 mmol) were dissolved in MeCN (25 cm3) and stirred for 16 h.
After this time the solution was filtered through Celite, the solvent
was removed under vacuum and the solid was kept. Crystallisation
occurred from slow diffusion of Et2O into a concentrated MeCN
solution. Yield: 247 mg of green crystals (92%). dH (300 MHz,
CD3CN): 8.46 (1H, t, J = 8.5 Hz, py-4), 8.14 (2H, d, J = 2 Hz,
imidazol-2-ylidine), 7.72 (2H, d, J = 8.5 Hz, py-3,5), 7.42 (2H,
dd, J = 8.5, 7.0 Hz, Ar), 7.27–7.34 (6H, m, Ar), 2.54 (4H, septet,
Nickel{2,6-bis-[(3-(2,6-diisopropylphenyl)-imidazol-2-ylidene]-
pyridine}bromide bromide, 3·(Br)−. To
a
solution of
NiBr2(DME) (116 mg, 0.38 mmol) in THF (15 cm3) was
added a solution of 2 (200 mg, 0.38 mmol) in THF (15 cm3) at
0 ◦C. The reaction was stirred for 15 min, then warmed to room
temperature and stirred for 16 h. After this time, the solvent
was removed under vacuum and the solid product was washed
with light petroleum (20 cm3) and dried. Crystallisation occurred
from slow diffusion of ether into a concentrated dicloromethane
solution. Yield: 210 mg of an orange solid (74%). dH (300 MHz,
i
J = 7.0 Hz, Pr CH), 1.94 (3H, s, MeCN), 1.19 and 1.08 (each
i
12H, d, J = 7.0 Hz, Pr CH3) ppm. dC (100.63 MHz, CD3CN):
151.81 (C, Ar), 149.33 (CH, Ar), 145.92, 132,64 (C, Ar), 132.25,
i
128.32, 125.12, 118.67, 109.92 (CH, Ar), 28.72 (CH, Pr), 23.90,
i
23.62 (CH3, Pr) ppm. dF (282.4 MHz, CD3CN): −151.27. Calc.
for C37H44N6NiB2F8: C 55.20; H 5.51; N 10.44. Found: C 55.27;
H 5.59; N 10.51%.
i
CD2Cl2): 6.0–9.2 (13H, br m, Ar), 0.5–3.0 (38H, br m, Pr
CH/CH3 + acetone) ppm. dC (75.5 MHz, CD2Cl2): 164.62,
trans-Nickel{2,6-bis-[(3-(2,6-diisopropylphenyl)-imidazol-2-yli-
dene]pyridine}-bis-trifluoromethanesulfonate tetrahydrofuran, 5.
Compound 3·(Br)− (250 mg, 0.33 mmol) and AgOTf (171 mg,
0.66 mmol) were dissolved in THF (25 cm3) and stirred for 4 h.
After this time, the resultant green solution was filtered through
Celite, the solvent was removed under vacuum and the solid
product was dried under vacuum. Crystallisation occurred by
slow diffusion of light petroleum to a concentrated THF solution.
Yield: 300 mg of green crystals (94%). leff: 2.86 B.M. Calc. for
C41H49N5O7F6NiS2: C 51.26; H 5.14; N 7.29. Found: C 51.18; H
5.23; N 7.16%.
150.88, 144.55, 134.00, 130.09, 127.86, 123.58, 118.41, 109.83
i
(C/CH, Ar), 28.60, 24.42, 22.91 (CH/CH3, Pr) ppm. Calc. for
C35H41N5NiBr2: C 56.03; H 5.51; N 9.33. Found: C 55.97; H 5.41;
N 9.41%.
Nickel{2,6-bis-[(3-(2,6-diisopropylphenyl)-imidazol-2-ylidene]-
3,5-dimethylpyridine}bromide bromide, 3Me·(Br)−. Compound
2Me (250 mg, 0.45 mmol) and NiBr2(DME) (96 mg, 0.45 mmol)
were suspended in THF (20 cm3) and stirred for 16 h at room
temperature. After this time, solvents were removed in vacuo,
affording 326 mg of the title compound as an orange powder
(94%). dH (400 MHz, C6D6): 8.32 (1H, s, py-H), 8.28 (2H, br s,
imidazol-2-ylidene), 7.35 (2H, t, J = 7.5 Hz, Ar), 7.11 (4H, br d,
J = 7.5 Hz, Ar), 7.01 (2H, br s, imidazol-2-ylidene), 2.89 (6H, s,
py-Me), 2.46 (4H, septet, J = 6.5 Hz, iPr CH), 1.19 and 1.05 (each
12H, d, J = 6.5 Hz, iPr CH3) ppm. dC (100.6 MHz, C6D6): 182.18
(C, CNHC), 167.10 (C, Ar), 152.86 (CH, Ar), 148.58, 145.21, 134.98
(C, Ar), 130.91, 128.55, 124.38 (CH, Ar), 120.91 (C, Ar), 119.63
Bis-[2,6-bis-[(3-(2,6-diisopropylphenyl)-imidazol-2-ylidene]-3,5-
dimethylpyridine disilver (hexasilver octaiodide), 6Me·(Ag6I8)2−.
Ag2O (232 mg, 1.00 mol) and compound 1Me·(I)− (816 mg,
2
1.00 mmol) were mixed as powders, dissolved in dichloromethane
(40 cm3) and stirred for 4 h with the exclusion of light. After
this time, the solution was concentrated, filtered through Celite
and ether (200 cm3) was added to complete precipitation. The
white solid formed was filtered and dried in vacuo. Crystallisation
occurred by slow diffusion of ether into a CDCl3 solution. dH
(400 MHz, C6D6): 7.66–7.87 (2H, m, Ar), 7.39–7.48 (2H, m,
Ar), 7.18–7.32 (3H, m, Ar), 6.96–7.15 (4H, m, Ar), 2.51 (4H,
i
i
(CH, Ar), 29.42 (CH, Pr), 25.26, 23.68 (CH3, Pr), 19.50 (CH3,
py-Me) ppm. Calc. for C37H45N5NiBr2: C 57.10; H 5.83; N 9.00.
Found: C 56.96; H 5.69; N 8.82%.
Nickel{2,6-bis-[(3-(2,6-diisopropylphenyl)-imidazol-2-ylidene]-
pyridine}bromide hexafluorophosphate, 3·(PF6)−. Compound
3·(Br)− (150 mg, 0.20 mmol) and KPF6 (171 mg, 0.66 mmol) were
dissolved in THF (20 cm3) and stirred for 16 h. After this time the
solution was filtered through Celite and the solvent was removed
under vacuum. Crystallisation occurred by slow diffusion of ether
into a concentrated dichloromethane solution. Yield: 150 mg of
orange crystals, (92%). dH (400 MHz, CD2Cl2): 8.43 (1H, t, J =
8.0 Hz, py-4), 7.95 (2H, s, imidazol-2-ylidine CH), 7.69 (2H, d, J =
8.0 Hz, py-3,5), 7.36 (2H, t, J = 8.0 Hz, Ph-4), 7.13 (4H, d, J =
8.0 Hz, Ph-3,5), 7.00 (2H, s, imidazol-2-ylidine CH), 2.485 (4H,
i
br s, Pr CH), 2.40 (6H, s, py-Me), 1.24, 1.14 (each 12H, br s,
iPr CH3) ppm. dC (100.6 MHz, C6D6): 188.27 (C, CNHC), 147.51,
147.25 (C, Ar), 146.58, 146.25 (CH, Ar), 145.82, 145.08, 134.80
(C, Ar), 130.82, 130.58, 124.34, 123.71, 122.41 (CH, Ar), 28.42
(CH, iPr), 24.81, 24.49 (CH3, iPr), 19.01 (CH3, py-Me) ppm. Calc.
for C74H90N10Ag8I8: C 29.65; H 3.03; N 4.67. Found: C 29.77, H
3.10; N 4.63%.
Nickel-{[2,6-bis-[(3-(2,6-diisopropylphenyl)-imidazol-2-ylidene]-
3,5-dimethylpyridine}bromide (silver diiodide), 3Me·(AgI2)−.
Compound 6Me·(Ag6I8)2− (450 mg, 0.44 mmol) and NiBr2(DME)
1092 | Dalton Trans., 2008, 1087–1094
This journal is
The Royal Society of Chemistry 2008
©